John Lettieri

Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics

Chetan Lathia, John Lettieri, Frank Cihon et al. · Cancer Chemotherapy and Pharmacology · 2005 · 207 citations

Sorafenib Clinical Pharmacokinetics, Medicine, Clinical Pharmacology +5

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

David E. Nix, William A. Watson, Michelle E. Lener et al. · Clinical Pharmacology & Therapeutics · 1989 · 186 citations

Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses

John Lettieri, Mark Rogge, Lee Kaiser et al. · Antimicrobial Agents and Chemotherapy · 1992 · 130 citations

Pharmacological Study, Antibiotics, Medicine +10

Pharmacokinetics of a Once-Daily Oral Dose of Moxifloxacin (Bay 12-8039), a New Enantiomerically Pure 8-Methoxy Quinolone

John T. Sullivan, Marilyn Woodruff, John Lettieri et al. · Antimicrobial Agents and Chemotherapy · 1999 · 117 citations · Full text

Drug Safety, Bay 12-8039, Therapeutic Drug Monitoring +12

Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin

R. Wayne Frost, KC Lasseter, A. Noe et al. · Antimicrobial Agents and Chemotherapy · 1992 · 101 citations · Full text

Urology, Biochemistry, Medicine +10